# Bioequivalence Study of AG2202

> **NCT06549504** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Ahn-Gook Pharmaceuticals Co.,Ltd** · enrollment: 34 (estimated)

## Conditions studied

- Bioequivalence Study

## Interventions

- **DRUG:** AG2202T
- **DRUG:** AG2202R

## Key facts

- **NCT ID:** NCT06549504
- **Lead sponsor:** Ahn-Gook Pharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2024-09
- **Final completion:** 2024-09
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06549504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06549504, "Bioequivalence Study of AG2202". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06549504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*